| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-066413 |
| cik | 1936258 |
| name | NEWAMSTERDAM PHARMA CO N.V. |
| sic | 2834 |
| countryba | NL |
| stprba | |
| cityba | NARRDEN |
| zipba | 1411 DC |
| bas1 | GOOIMEER 2-35 |
| bas2 | |
| baph | 35 206 2971 |
| countryma | NL |
| stprma | |
| cityma | NARRDEN |
| zipma | 1411 DC |
| mas1 | GOOIMEER 2-35 |
| mas2 | |
| countryinc | NL |
| stprinc | |
| ein | 000000000 |
| former | NEWAMSTERDAM PHARMA CO B.V. |
| changed | 20220701 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 08:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | nams-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066413 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 15213000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20240331 | Change In Fair Value Of Warrants | 30248000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066413 | 20241231 | Common Stock Shares Issued | 108064340.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Common Stock Shares Outstanding | 108064340.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Common Stock Value | 13444000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Common Stock Value | 13968000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Comprehensive Income Net Of Tax | -39527000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20250331 | Derivative Liabilities Current | 23523000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Earnings Per Share Diluted | -1.0600 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Liabilities And Stockholders Equity | 864620000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Liabilities And Stockholders Equity | 818413000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Liabilities Current | 106918000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Net Income Loss | -93767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Operating Lease Liability Noncurrent | 137000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Payments Of Stock Issuance Costs | 1586000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= December2024 Offering; | ||
| 0000950170-25-066413 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 989000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 12500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Retained Earnings Accumulated Deficit | -558571000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Shares Outstanding | 108064340.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Shares Outstanding | 112169291.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20231231 | Stockholders Equity | 10173000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Pre Funded Warrants Exercised | -162000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Stock Option Exercised | 116000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Warrants Exercised | 121000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.1200 | EUR | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Depreciation Depletion And Amortization | 52000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Earnings Per Share Basic | -0.3400 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -2496000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Increase Decrease In Prepayments And Other Receivables | -956000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20241231 | Liabilities | 107120000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Liabilities | 41050000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Net Cash Provided By Used In Operating Activities | -54602000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Net Income Loss | -39527000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Operating Lease Right Of Use Asset | 431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Payments To Acquire Available For Sale Securities Debt | 9629000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Research And Development Expense | 44751000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Shares Outstanding | 89720836.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Stock Option Exercised | -549000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20241231 | Additional Paid In Capital Common Stock | 1298160000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Cash And Cash Equivalents At Carrying Value | 748420000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Common Stock Shares Outstanding | 112169291.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Comprehensive Income Net Of Tax | -39560000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Earnings Per Share Diluted | -0.3400 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Employee Receivables Current | 4951000.0000 | USD | 0 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Increase Decrease In Accounts Payable | 2251000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Increase Decrease In Prepayments And Other Receivables | -16031000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Investment Income Interest | 7351000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Issuance Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Cost | 189207000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20241231 | Prepaid Expense And Other Assets Current | 24272000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Proceeds From Stock Options Exercised | 440000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Retained Earnings Accumulated Deficit | -598098000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Selling General And Administrative Expense | 14453000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20231231 | Stockholders Equity | 288393000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Stockholders Equity | 1298160000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stockholders Equity | -598098000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 452461.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 909140.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Shares Warrants Exercised | 926698.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Issuance Of Earnout Shares | 226000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Stock Option Exercised | 2991000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Assets Current | 817304000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -27094000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Change In Fair Value Of Derivative Earnout And Warrants | 38950000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20240331 | Comprehensive Income Net Of Tax | -93767000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20240331 | Depreciation Depletion And Amortization | 15000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Earnings Per Share Basic | -1.0600 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -93767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Increase Decrease In Accounts Payable | -8311000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Increase Decrease In Deferred Revenue | -1401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Net Cash Provided By Used In Operating Activities | -36468000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Operating Lease Liability Noncurrent | 202000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Prepaid Expense And Other Assets Current | 8827000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Proceeds From Stock Options Exercised | 7922000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Proceeds From Warrant Exercises | 183000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Stockholders Equity | 11113000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20241231 | Stockholders Equity | 13444000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Vested | 142795.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Pre Funded Warrants Exercised | 162000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Warrants Exercised | 19795000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Warrants Exercised | 19674000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Accounts Payable And Other Accrued Liabilities Current | 8021000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Accounts Payable Current | 6087000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 4467000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 7965000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 7965000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Amortization Of Financing Costs And Discounts | -513000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Assets | 864620000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Assets | 818413000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 481147000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 143193000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Change In Fair Value Of Warrants | -13762000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Selling General And Administrative Expense | 27152000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066413 | 20250331 | Deferred Revenue Current | 3030000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Derivative Earnout Liability Current | 44798000.0000 | USD | 0 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | -2418000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Investment Income Interest | 3083000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Liabilities Current | 40913000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Net Cash Provided By Used In Financing Activities | 6519000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Noncash Rent Expense | 1000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20240331 | Operating Income Loss | -55482000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Operating Lease Liability Current | 252000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Proceeds From Offering Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Costs | 190481000.0000 | USD | 1 | 0000950170-25-066413 | Subsidiary Sale Of Stock= February2024 Offering; | ||
| 0000950170-25-066413 | 20231231 | Stockholders Equity | -316973000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20241231 | Stockholders Equity | -558571000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20250331 | Stockholders Equity | 4434000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066413 | 20241231 | Accounts Payable Current | 4744000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Cash And Cash Equivalents At Carrying Value | 771743000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 748420000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Common Stock Shares Authorized | 400000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Comprehensive Income Net Of Tax | -93767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Deferred Revenue Current | 6008000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 3771000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 4293000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -39527000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -1381000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Intangible Assets Net Including Goodwill | 534000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Intangible Assets Net Including Goodwill | 502000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Marketable Securities Current | 62447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Marketable Securities Current | 60057000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Net Cash Provided By Used In Investing Activities | -385000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 4434000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Additional Paid In Capital Common Stock | 1357059000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Assets Current | 863413000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Change In Fair Value Of Earnout | 8702000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Common Stock Shares Authorized | 400000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Derivative Liabilities Current | 37514000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Issuance Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Cost | 189966000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20240331 | Issuance Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Cost | 759000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Net Cash Provided By Used In Financing Activities | 198180000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Noncash Rent Expense | 3000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20241231 | Operating Lease Liability Current | 246000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Proceeds From Warrant Exercises | 8763000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Receivable Related To Exercise Of Warrants | 1271000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20231231 | Stockholders Equity | 4422000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066413 | 20240331 | Stockholders Equity | 4422000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066413 | 20240331 | Stockholders Equity | -410740000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066413 | 20250331 | Stockholders Equity | 13968000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Operating Expenses | 56883000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Net Cash Provided By Used In Investing Activities | 2855000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Operating Income Loss | -68925000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Operating Lease Right Of Use Asset | 369000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Payments Of Stock Issuance Costs | 515000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= February2024 Offering; | ||
| 0000950170-25-066413 | 20240331 | Payments To Acquire Productive Assets | 385000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Profit Loss | -93767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Property Plant And Equipment Net | 242000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2978000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Share Based Compensation | 7918000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Share Based Compensation | 15213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20231231 | Shares Outstanding | 82469768.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Stockholders Equity | 411803000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Stockholders Equity | 807008000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20241231 | Stockholders Equity | 757500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Stockholders Equity | 777363000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Stock Issuance Of Ordinary Shares And Pre Funded Warrants Shares | 5871909.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Stock Option Exercised | -609000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Pre Funded Warrants Exercised | 1293938.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Vesting Of Restricted Shares | 18000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20241231 | Accounts Payable And Other Accrued Liabilities Current | 13608000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 15213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 340450000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 771743000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Change In Fair Value Of Derivative Earnout And Warrants | -17754000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Change In Fair Value Of Earnout | -3992000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.1200 | EUR | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Common Stock Shares Issued | 112169291.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Comprehensive Income Net Of Tax | -33000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066413 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -4953000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Increase Decrease In Deferred Revenue | -2978000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Issuance Of Earnout Shares Amount | 40807000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Operating Expenses | 71903000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -33000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Payments To Acquire Productive Assets | 16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Profit Loss | -39527000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20250331 | Property Plant And Equipment Net | 238000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Research And Development Expense | 42430000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066413 | 20231231 | Stockholders Equity | 590771000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20241231 | Stockholders Equity | 4467000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066413 | 20250331 | Stockholders Equity | 1357059000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Issuance Of Earnout Shares | 1743136.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Issuance Of Earnout Shares | 40807000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Stock Option Exercised | 2875000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Vesting Of Restricted Shares | -18000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Warrants Exercised | 412000.0000 | USD | 1 | 0000950170-25-066413 | |||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Warrants Exercised | 2000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 909140.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Shares Warrants Exercised | 15942.0000 | shares | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Issuance Of Earnout Shares | 40581000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066413 | 20240331 | Stock Issued During Period Value Stock Option Exercised | 60000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Common Stock; | ||
| 0000950170-25-066413 | 20250331 | Stock Issued During Period Value Warrants Exercised | 410000.0000 | USD | 1 | 0000950170-25-066413 | Equity Components= Additional Paid In Capital; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Deferred Revenue Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Payments To Acquire Productive Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Productive Assets | The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Derivative Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Derivative Liability, Current | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Intangible Assets Net Including Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Including Goodwill) | Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Change In Fair Value Of Warrants | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Change in Fair Value of Warrants | Change in fair value of warrants. |
| Proceeds From Offering Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Costs | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Proceeds from offering of ordinary shares and pre-funded warrants, net of issuance costs | Proceeds from offering of ordinary shares and pre-funded warrants, net of issuance costs |
| Receivable Related To Exercise Of Warrants | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Receivable related to exercise of warrants | Receivable related to exercise of warrants |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Change In Fair Value Of Derivative Earnout And Warrants | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Change In Fair Value Of Derivative Earnout And Warrants | Change in fair value of derivative earnout and warrants. |
| Increase Decrease In Prepayments And Other Receivables | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Increase Decrease In Prepayments And Other Receivables | Increase decrease in prepayments and other receivables. |
| Stock Issued During Period Value Stock Option Exercised | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Stock Option Exercised | Stock issued during period value stock option exercised. |
| Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale | Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Derivative Earnout Liability Current | 0000950170-25-066413 | 1 | 0 | monetary | I | C | Derivative Earnout Liability, Current | Derivative earnout liability, current. |
| Issuance Of Earnout Shares Amount | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Issuance Of Earnout Shares Amount | Issuance of earnout shares amount |
| Stock Issuance Of Ordinary Shares And Pre Funded Warrants Shares | 0000950170-25-066413 | 1 | 0 | shares | D | Stock Issuance of Ordinary Shares and Pre-funded Warrants, Shares | stock Issuance of ordinary shares and pre-funded warrants, shares. | |
| Stock Issued During Period Value Issuance Of Earnout Shares | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Issuance of Earnout Shares | Value of stock issued during period issuance of earnout shares. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Noncash Rent Expense | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Noncash Rent Expense | Noncash rent expense. |
| Stock Issued During Period Shares Issuance Of Earnout Shares | 0000950170-25-066413 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Issuance of Earnout Shares | Number of shares issued during the period issuance of earnout shares. | |
| Stock Issued During Period Value Vesting Of Restricted Shares | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Stock Issued During Period Value Vesting Of Restricted Shares | Stock issued during period value vesting of restricted shares. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Stock Issued During Period Shares Restricted Stock Award Vested | 0000950170-25-066413 | 1 | 0 | shares | D | Stock Issued During Period Shares Restricted Stock Award Vested | Stock issued during period shares restricted stock award vested. | |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Stock Issued During Period Value Pre Funded Warrants Exercised | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Pre Funded Warrants Exercised | Stock issued during period value pre funded warrants exercised. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Change In Fair Value Of Earnout | 0000950170-25-066413 | 1 | 0 | monetary | D | D | Change in Fair Value of Earnout | Change in fair value of earnout. |
| Employee Receivables Current | 0000950170-25-066413 | 1 | 0 | monetary | I | D | Employee Receivables, Current | Employee receivables, current. |
| Issuance Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Cost | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Issuance of Ordinary Shares and Pre-Funded Warrants, net of Issuance Cost | Issuance of ordinary shares and pre-funded warrants, net of issuance cost. |
| Stock Issued During Period Shares Warrants Exercised | 0000950170-25-066413 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Warrants Exercised | Stock Issued During Period, Shares, Warrants Exercised. | |
| Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Pre Funded Warrants Exercised | 0000950170-25-066413 | 1 | 0 | shares | D | Stock Issued During Period Shares Pre Funded Warrants Exercised | Stock issued during period shares pre funded warrants exercised. | |
| Stock Issued During Period Value Warrants Exercised | 0000950170-25-066413 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Warrants Exercised | Stock Issued During Period, Value, Warrants Exercised |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066413 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-066413 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepayments and other receivables | 0 |
| 0000950170-25-066413 | 2 | 5 | BS | 0 | H | Employee Receivables Current | 0000950170-25-066413 | Employee receivables | 0 |
| 0000950170-25-066413 | 2 | 6 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-066413 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-066413 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
| 0000950170-25-066413 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating right of use asset | 0 |
| 0000950170-25-066413 | 2 | 10 | BS | 0 | H | Intangible Assets Net Including Goodwill | us-gaap/2024 | Intangible assets | 0 |
| 0000950170-25-066413 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-066413 | 2 | 14 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-066413 | 2 | 15 | BS | 0 | H | Accounts Payable And Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-066413 | 2 | 16 | BS | 0 | H | Deferred Revenue Current | us-gaap/2024 | Deferred revenue, current | 0 |
| 0000950170-25-066413 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Lease liability, current | 0 |
| 0000950170-25-066413 | 2 | 18 | BS | 0 | H | Derivative Earnout Liability Current | 0000950170-25-066413 | Derivative earnout liability, current | 0 |
| 0000950170-25-066413 | 2 | 19 | BS | 0 | H | Derivative Liabilities Current | us-gaap/2024 | Derivative warrant liabilities | 0 |
| 0000950170-25-066413 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-066413 | 2 | 21 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease liability, net of current portion | 0 |
| 0000950170-25-066413 | 2 | 22 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-066413 | 2 | 23 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 10) | 0 |
| 0000950170-25-066413 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary shares | 0 |
| 0000950170-25-066413 | 2 | 26 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-066413 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated loss | 0 |
| 0000950170-25-066413 | 2 | 28 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0000950170-25-066413 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders' equity | 0 |
| 0000950170-25-066413 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0000950170-25-066413 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Ordinary shares, par value | 0 |
| 0000950170-25-066413 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Ordinary shares, authorized | 0 |
| 0000950170-25-066413 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Ordinary shares, issued | 0 |
| 0000950170-25-066413 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ordinary shares, outstanding | 0 |
| 0000950170-25-066413 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Revenue | 0 |
| 0000950170-25-066413 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development expenses | 0 |
| 0000950170-25-066413 | 4 | 4 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative expenses | 0 |
| 0000950170-25-066413 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-066413 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0000950170-25-066413 | 4 | 8 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0000950170-25-066413 | 4 | 9 | IS | 0 | H | Change In Fair Value Of Earnout | 0000950170-25-066413 | Fair value change - earnout | 1 |
| 0000950170-25-066413 | 4 | 10 | IS | 0 | H | Change In Fair Value Of Warrants | 0000950170-25-066413 | Fair value change - warrants | 1 |
| 0000950170-25-066413 | 4 | 11 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign exchange gains/(losses) | 0 |
| 0000950170-25-066413 | 4 | 12 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before tax | 0 |
| 0000950170-25-066413 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Loss for the year | 0 |
| 0000950170-25-066413 | 4 | 15 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized gain/(loss) on available-for-sale securities, net of tax | 0 |
| 0000950170-25-066413 | 4 | 16 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss for the year, net of tax | 0 |
| 0000950170-25-066413 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-066413 | 4 | 19 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-066413 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-066413 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, shares | 0 |
| 0000950170-25-066413 | 5 | 14 | EQ | 0 | H | Issuance Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Cost | 0000950170-25-066413 | Issuance of ordinary shares and pre-funded warrants | 0 |
| 0000950170-25-066413 | 5 | 15 | EQ | 0 | H | Stock Issuance Of Ordinary Shares And Pre Funded Warrants Shares | 0000950170-25-066413 | Stock issuance of ordinary shares and pre-funded warrants, shares | 0 |
| 0000950170-25-066413 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value Pre Funded Warrants Exercised | 0000950170-25-066413 | Exercise of Pre-Funded Warrants | 0 |
| 0000950170-25-066413 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Pre Funded Warrants Exercised | 0000950170-25-066413 | Exercise of Pre-Funded Warrants,Shares | 0 |
| 0000950170-25-066413 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Issuance Of Earnout Shares | 0000950170-25-066413 | Issuance of Earnout Shares | 0 |
| 0000950170-25-066413 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Issuance Of Earnout Shares | 0000950170-25-066413 | Issuance of Earnout Shares, shares | 0 |
| 0000950170-25-066413 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Warrants Exercised | 0000950170-25-066413 | Exercise of warrants | 0 |
| 0000950170-25-066413 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Warrants Exercised | 0000950170-25-066413 | Exercise of warrants, shares | 0 |
| 0000950170-25-066413 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Stock Option Exercised | 0000950170-25-066413 | Exercise of stock options | 0 |
| 0000950170-25-066413 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options, shares | 0 |
| 0000950170-25-066413 | 5 | 24 | EQ | 0 | H | Stock Issued During Period Value Vesting Of Restricted Shares | 0000950170-25-066413 | Vesting of RSUs | 0 |
| 0000950170-25-066413 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Vested | 0000950170-25-066413 | Vesting of RSUs, shares | 0 |
| 0000950170-25-066413 | 5 | 26 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation | 0 |
| 0000950170-25-066413 | 5 | 27 | EQ | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total profit or loss and comprehensive loss for the year | 0 |
| 0000950170-25-066413 | 5 | 28 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-066413 | 5 | 29 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, shares | 0 |
| 0000950170-25-066413 | 6 | 10 | CF | 0 | H | Profit Loss | us-gaap/2024 | Loss for the period | 0 |
| 0000950170-25-066413 | 6 | 12 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0000950170-25-066413 | 6 | 13 | CF | 0 | H | Noncash Rent Expense | 0000950170-25-066413 | Non-cash rent expense | 0 |
| 0000950170-25-066413 | 6 | 14 | CF | 0 | H | Change In Fair Value Of Derivative Earnout And Warrants | 0000950170-25-066413 | Fair value change - derivative earnout and warrants | 0 |
| 0000950170-25-066413 | 6 | 15 | CF | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign exchange (gains)/losses | 1 |
| 0000950170-25-066413 | 6 | 16 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of premium/discount on available-for-sale debt securities | 0 |
| 0000950170-25-066413 | 6 | 17 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0000950170-25-066413 | 6 | 19 | CF | 0 | H | Increase Decrease In Prepayments And Other Receivables | 0000950170-25-066413 | Changes in prepayments (current and non-current) and other receivables | 1 |
| 0000950170-25-066413 | 6 | 20 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Changes in accounts payable | 0 |
| 0000950170-25-066413 | 6 | 21 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Changes in accrued expenses and other current liabilities | 0 |
| 0000950170-25-066413 | 6 | 22 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Changes in deferred revenue | 0 |
| 0000950170-25-066413 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-066413 | 6 | 25 | CF | 0 | H | Payments To Acquire Productive Assets | us-gaap/2024 | Purchase of property, plant and equipment, including internal use software | 1 |
| 0000950170-25-066413 | 6 | 26 | CF | 0 | H | Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | Maturity of available-for-sale debt securities | 0 |
| 0000950170-25-066413 | 6 | 27 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | Purchase of available-for-sale debt securities | 1 |
| 0000950170-25-066413 | 6 | 28 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash (used in)/provided by investing activities | 0 |
| 0000950170-25-066413 | 6 | 30 | CF | 0 | H | Proceeds From Offering Of Ordinary Shares And Pre Funded Warrants Net Of Issuance Costs | 0000950170-25-066413 | Proceeds from February 2024 offering of Ordinary Shares and Pre-Funded Warrants | 0 |
| 0000950170-25-066413 | 6 | 31 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Transaction costs on issue of Ordinary Shares and Pre-Funded Warrants | 1 |
| 0000950170-25-066413 | 6 | 32 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from exercise of warrants | 0 |
| 0000950170-25-066413 | 6 | 33 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of options | 0 |
| 0000950170-25-066413 | 6 | 34 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Payment of withholding taxes related to net share settlement of exercised options | 1 |
| 0000950170-25-066413 | 6 | 35 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-066413 | 6 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0000950170-25-066413 | 6 | 37 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Foreign exchange differences | 0 |
| 0000950170-25-066413 | 6 | 38 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash at the beginning of the period | 0 |
| 0000950170-25-066413 | 6 | 39 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash at the end of the period | 0 |
| 0000950170-25-066413 | 6 | 41 | CF | 0 | H | Receivable Related To Exercise Of Warrants | 0000950170-25-066413 | Receivable related to exercise of warrants | 0 |
| 0000950170-25-066413 | 6 | 42 | CF | 0 | H | Issuance Of Earnout Shares Amount | 0000950170-25-066413 | Issuance of earnout shares | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |